Navigation Links
Odyssey Thera Announces U.S. Patent for Technologies Enabling Protein Interaction Screening and Directed Evolution
Date:1/5/2011

SAN RAMON, Calif., Jan. 5, 2011 /PRNewswire/ -- Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167.  The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays (PCA).  The patent, the eighteenth assigned to Odyssey Thera, further protects assays utilizing fragments of inherently fluorescent proteins, and the use of these assays for high-throughput screening of defined panels of proteins.  The strategy is applicable in any cell type and using a wide range of reporters and detection methods.  The invention enables identification and validation of genes and proteins involved in any cellular process, and also provides assays to study the effects drugs and gene expression or knockout on specific pathways.

"This patent significantly extends the reach of Odyssey Thera's technology platform," said John K. Westwick, Ph.D., Odyssey Thera President and CEO.  "The assays and their use in gene vs. library and library vs. library screening provide a uniquely powerful strategy for biotherapeutic identification and optimization, diagnostic and biomarker development, the discovery of genetic modifiers of animal and plant cell traits, and bioprocess engineering."

About Odyssey Thera

Odyssey Thera, Inc. is a technology company committed to developing breakthroughs in cellular analysis and engineering.  Odyssey Thera's technologies measure pathway activity within living cells, and are applicable to therapeutic discovery and development, engineering of any cell type or species, live animal imaging, and diagnostic and bioprocess applications.  To learn more about Odyssey Thera, please visit www.odysseythera.com.


'/>"/>
SOURCE Odyssey Thera, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Odyssey Thera to Participate in Expanded EPA Initiative
2. Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training
3. Stereotaxis and Siemens Promote Integrated Odyssey(TM) Solutions
4. Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones
5. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
6. DJO Incorporated Acquires Manufacturer of Compression Therapy Products, Elastic Therapy, Inc.
7. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
8. Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
9. Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference
10. Graymark Healthcares Sleep Apnea Therapy Program Services Record Number of Patients in Q4 2010
11. Medco Extends URAC Accreditation to Drug Therapy Management, PBM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
Breaking Medicine News(10 mins):